Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease

Mohammad Reza Mehrabi(University of Vienna), Helmut-D. Glogar(University of Vienna), Johann Wojta(Medical University of Vienna), Nermin Serbecic(University of Vienna), T. Cameron Wild(Städtisches Klinikum Dessau), Richard Pacher(University of Vienna), Forouzan Tamaddon(University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), G. Mall(Purdue University West Lafayette)
Cardiovascular Research
October 21, 2002
10.1016/s0008-6363(02)00591-6
Cited by 51

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645